| Randi Michele Wright, CNP | |
|
307 N Main St, Cave City, AR 72521-9700 | |
| (870) 283-5550 | |
| Not Available |
| Full Name | Randi Michele Wright |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 307 N Main St, Cave City, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730609439 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A005194 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White River Medical Center | Batesville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fore Family Practice Llc | 7416197918 | 2 |
News Archive
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
Cancer Research UK has given a number of prestigious grants to new investigators who are set to become the eminent cancer scientists of the future.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
› Verified 5 days ago
| Entity Name | Fore Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174961239 PECOS PAC ID: 7416197918 Enrollment ID: O20140204001346 |
News Archive
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
Cancer Research UK has given a number of prestigious grants to new investigators who are set to become the eminent cancer scientists of the future.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randi Michele Wright, CNP 300 S Mount Auburn Rd Ste 100, Cape Girardeau, MO 63703-4902 Ph: () - | Randi Michele Wright, CNP 307 N Main St, Cave City, AR 72521-9700 Ph: (870) 283-5550 |
News Archive
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
Cancer Research UK has given a number of prestigious grants to new investigators who are set to become the eminent cancer scientists of the future.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
› Verified 5 days ago
Brittany Nicole Barnett, APRN-FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 63 Dalton Dr, Cave City, AR 72521 Phone: 870-847-3169 | |
Matthew Barnett, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 63 Dalton Dr, Cave City, AR 72521 Phone: 870-283-2196 | |
Mrs. Amber Lea Clements-fore, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 307 N Main St, Cave City, AR 72521 Phone: 870-283-5550 Fax: 870-283-6222 | |
Sarah Lynn Wycough, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 301 S Main St, Cave City, AR 72521 Phone: 870-283-5353 | |
Myra E Kendall, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 301 S Main St, Cave City, AR 72521 Phone: 870-283-5353 Fax: 870-283-5988 |